Literature DB >> 19084354

Salvage gamma knife stereotactic radiosurgery for surgically refractory trigeminal neuralgia.

Andrew S Little1, Andrew G Shetter, Mary E Shetter, Udaya K Kakarla, C Leland Rogers.   

Abstract

PURPOSE: To evaluate the clinical outcome of patients with surgically refractory trigeminal neuralgia (TN) treated with rescue gamma knife radiosurgery (GKRS). METHODS AND MATERIALS: Seventy-nine patients with typical TN received salvage GKRS between 1997 and 2002 at the Barrow Neurological Institute (BNI). All patients had recurrent pain following at least one prior surgical intervention. Prior surgical interventions included percutaneous destructive procedures, microvascular decompression (MVD), or GKRS. Thirty-one (39%) had undergone at least two prior procedures. The most common salvage dose was 80 Gy, although 40-50 Gy was typical in patients who had received prior radiosurgery. Pain outcome was assessed using the BNI Pain Intensity Score, and quality of life was assessed using the Brief Pain Inventory.
RESULTS: Median follow-up after salvage GKRS was 5.3 years. Actuarial analysis demonstrated that at 5 years, 20% of patients were pain-free and 50% had pain relief. Pain recurred in patients who had an initial response to GKRS at a median of 1.1 years. Twenty-eight (41%) required a subsequent surgical procedure for recurrence. A multivariate Cox proportional hazards model suggested that the strongest predictor of GKRS failure was a history of prior MVD (p=0.029). There were no instances of serious morbidity or mortality. Ten percent of patients developed worsening facial numbness and 8% described their numbness as "very bothersome."
CONCLUSIONS: GKRS salvage for refractory TN is well tolerated and results in long-term pain relief in approximately half the patients treated. Clinicians may reconsider using GKRS to salvage patients who have failed prior MVD.

Entities:  

Mesh:

Year:  2008        PMID: 19084354     DOI: 10.1016/j.ijrobp.2008.08.048

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Stereotactic radiosurgery of essential trigeminal neuralgia using Leksell Gamma Knife model C with automatic positioning system: technical nuances and evaluation of outcome in 130 patients with at least 2 years follow-up after treatment.

Authors:  Motohiro Hayashi; Mikhail Chernov; Noriko Tamura; Takaomi Taira; Masahiro Izawa; Shoji Yomo; Mariko Nagai; Cheng-Siu Chang; Pavel Ivanov; Manabu Tamura; Yoshihiro Muragaki; Yoshikazu Okada; Hiroshi Iseki; Kintomo Takakura
Journal:  Neurosurg Rev       Date:  2011-06-24       Impact factor: 3.042

2.  Body mass index and response to stereotactic radiosurgery in the treatment of refractory trigeminal neuralgia: A retrospective cohort study.

Authors:  Mohamed H Khattab; Alexander D Sherry; Ellen Kim; Joshua Anderson; Guozhen Luo; Hong Yu; Dario J Englot; Lola B Chambless; Anthony J Cmelak; Albert Attia
Journal:  J Radiosurg SBRT       Date:  2020

3.  Clinical outcomes of gamma knife radiosurgery in the treatment of patients with trigeminal neuralgia.

Authors:  Ameer L Elaimy; Peter W Hanson; Wayne T Lamoreaux; Alexander R Mackay; John J Demakas; Robert K Fairbanks; Barton S Cooke; Sudheer R Thumma; Christopher M Lee
Journal:  Int J Otolaryngol       Date:  2011-10-25

4.  Gamma knife radiosurgery for typical trigeminal neuralgia: An institutional review of 108 patients.

Authors:  Ameer L Elaimy; Andrew F Lamm; John J Demakas; Alexander R Mackay; Wayne T Lamoreaux; Robert K Fairbanks; Robert D Pfeffer; Barton S Cooke; Benjamin J Peressini; Christopher M Lee
Journal:  Surg Neurol Int       Date:  2013-07-17

5.  Microvascular Decompression Versus Stereotactic Radiosurgery for Trigeminal Neuralgia: A Decision Analysis.

Authors:  Ian Berger; Nikhil Nayak; James Schuster; John Lee; Sherman Stein; Neil R Malhotra
Journal:  Cureus       Date:  2017-01-26

Review 6.  Treatment Outcomes in Trigeminal Neuralgia-A Systematic Review of Domains, Dimensions and Measures.

Authors:  Carolina Venda Nova; Joanna M Zakrzewska; Sarah R Baker; Richeal Ni Riordain
Journal:  World Neurosurg X       Date:  2020-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.